title: "Un-slugging" resistance to epidermal growth factor receptor inhibition. A positive outlook for the future of lung cancer therapy.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Winn
authors.forename: Rubin M
authors.initials: RM
authors.lastname: Tuder
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors / Q000096:biosynthesis / Q000187:drug effects
chemical_list: D011799:Quinazolines; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors; D000077156:Gefitinib